Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 15 images provide visual information about the product associated with Pregabalin NDC 70518-2571 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Pregabalin is a medication available in capsule form, with a strength of 50 mg per capsule. The package contains 60 capsules and the NDC number is 70518-2671-01. The manufacturer is Amneal Pharma, located in Ahmedabad, India. The medication should be stored at a temperature of 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) and should be kept out of reach of children. Exact expiration date and LOT # is not available. The medication should be used as directed, the details of which can be found in the package insert. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701.*
This is a description of Pregabalin in capsule form with a strength of 50 mg. There are a total of 90 capsules in the package, and the NDC number is 70518-2671-00. The manufacturer is Amneal Pharma, located in Ahmedabad, India. Storage instructions are provided, and the medication should be kept out of reach of children. Specific directions for use can be found in the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*
This is a formula commonly used to estimate the creatinine clearance (CLCr) in adults based on their age, weight, and serum creatinine levels. The formula differs slightly for female patients, who multiply their calculated CLCr by 0.85. However, without units accompanying the values, it is not possible to determine the specific units or reference ranges used for the calculations.*
The text indicates a chart showing the percentage of patients who experienced improvement in pain after taking pregabalin and placebo. The chart also shows the dosage of pregabalin administered to the patients. However, the chart is not available to evaluate the extent and scope of improvements.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.